PK Consumer Health Appoints Neil Lister as New CEO for Growth and Innovation

PK Consumer Health Appoints Neil Lister as New CEO

In a significant move to bolster its leadership, PK Consumer Health has announced the appointment of Neil Lister as Chief Executive Officer. This European consumer health group encompasses notable brands such as Lucovitaal, Puhdistamo, and HealthAid and is supported by Avista Healthcare Partners.

Neil Lister arrives at PK with over 25 years of extensive experience in the consumer health and goods sector. His impressive portfolio includes senior roles at renowned companies like Perrigo, Omega Pharma, and Procter & Gamble. Throughout his career, Lister has successfully led businesses across Europe and various international markets, making substantive contributions in brand development, commercial growth, innovation, and business transformation.

In a statement regarding his new role, Lister expressed excitement, stating, "I am thrilled to join PK Consumer Health and have been immensely impressed by the businesses, brands, and people within the group. Each of Lucovitaal, Puhdistamo, and HealthAid has unique identities, entrepreneurial cultures, and considerable room for further growth. Our goal is to build on the strengths that make these businesses thrive, while utilizing the broader group's scale and capabilities to generate additional value. There's a tremendous opportunity to expand our brands, speed up innovation and digital commerce, and provide an array of stellar consumer health products to a wider audience."

Tom Dean, Chairman of Avista Healthcare Partners, highlighted Lister's track record, saying, "Neil has devoted his career to cultivating robust consumer health brands and businesses in a multitude of international markets. He brings an extensive wealth of commercial and operational insight to PK. With PK representing three strong businesses poised for growth, Neil stands out as the ideal leader to guide the team in harnessing these opportunities, enhancing the entrepreneurial strengths of each entity, and navigating PK through its forthcoming growth phases."

Lister's promotion marks the beginning of a new chapter for PK Consumer Health, which aims to accelerate organic growth within its current operations while enhancing the overall capabilities of the group. The company is also exploring selective opportunities for expansion within the European consumer health market.

About PK Consumer Health

PK Consumer Health operates as a European consumer health group featuring PK Benelux, alongside its flagship brand Lucovitaal, as well as Puhdistamo in Finland and HealthAid in the UK. This group is dedicated to the development and marketing of a diverse range of health products including vitamins, minerals, and supplements. Their offerings are accessible across various channels such as drugstores, grocery stores, pharmacies, and e-commerce platforms.

The company is distinguished by its strong local market presence and innovation capabilities in product development and digital commerce, along with its extensive distribution network reaching over 30 countries with a portfolio of white-label and private-label medical devices.

About Avista Healthcare Partners

Founded in 2005 by Thompson Dean and David Burgstahler, Avista Healthcare Partners ranks as a leading private equity firm based in New York. The firm boasts an impressive investment portfolio exceeding $10 billion across more than 50 growth-focused healthcare enterprises worldwide. Avista collaborates with businesses that showcase strong leadership, stable cash flow, and promising growth trajectories, concentrating on sectors with robust expansion potential. The Avista team is reinforced by a cadre of seasoned strategic executives who enhance the investment process through insightful strategies aimed at long-term value creation and sustainable business growth.

For additional information about Avista Healthcare Partners, visit www.avistahealthcare.com and follow them on LinkedIn.